Jumpei Takeshita
Jumpei Takeshita publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.
- World rank
- #2,910,561 of 7,710,434 ranked researchers
- Rank in Japan
- #63,876 of 383,136
- Works
- 50
- Citations
- 2k
- Citations per work
- 39.2
What does Jumpei Takeshita research?
Jumpei Takeshita's work is mostly in Medicine (83%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4182.7%
- Medicine4182.7%
- Everything else510.7%
- Life Sciences36.6%
- 1Pulmonary and Respiratory Medicine46% of their works
- 2Oncology27% of their works
- 3Epidemiology9% of their works
- 4Cancer Research3% of their works
- 5Molecular Biology3% of their works
- 6Cardiology and Cardiovascular Medicine1% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Pneumocystis jirovecii pneumonia detection and treatment
- Cancer Diagnosis and Treatment
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
Which keywords describe Jumpei Takeshita's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, Metastasis and CT Screening.
- Pulmonary Sclerosing Hemangioma
- Pneumonia
- Malignant Pleural Mesothelioma
- BAP1 mutations
- Immune Checkpoint Blockade
- Genomic Profiles
- CT Screening
- Immunotherapy
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Metastasis
- Lung Cancer
- Small-Cell Lung Cancer
- PD-1 and PD-L1
- Cancer of Unknown Primary
- Pneumocystis
- Pulmonary Alveolar Microlithiasis
- Tissue of Origin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Clinical Trials282 topics
- Targeted Therapy282 topics
- Chemotherapy232 topics
- ALK Inhibitors171 topic
- EGFR Mutations171 topic
- Immunotherapy142 topics
- Metastasis142 topics
- CT Screening121 topic
- Lung Cancer121 topic
- Genomic Profiles111 topic
- Small-Cell Lung Cancer111 topic
- Immune Checkpoint Blockade51 topic
- PD-1 and PD-L151 topic
- BAP1 mutations31 topic
- Cancer of Unknown Primary31 topic
- Malignant Pleural Mesothelioma31 topic
- Pneumocystis31 topic
- Pneumonia31 topic
- Pulmonary Alveolar Microlithiasis31 topic
- Pulmonary Sclerosing Hemangioma31 topic
- Tissue of Origin31 topic
Where does Jumpei Takeshita work?
Jumpei Takeshita's main affiliation in the publication record is Foundation for Biomedical Research and Innovation, Japan.
How many publications and citations does Jumpei Takeshita have?
OpenAlex counts 50 works and 1,962 citations for Jumpei Takeshita, an h-index of 13, ranking #2,910,561 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jumpei Takeshita. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.